Raising Health

Andreessen Horowitz, a16z Bio + Health
undefined
11 snips
Feb 13, 2024 • 28min

Metrics for a Complex Machine with Josh Clemente

Josh Clemente, cofounder and president of Levels, discusses wearable tech for tracking biomarkers and the potential of AI in simplifying wearables data into actionable health profiles. He shares his journey from SpaceX to cofounding Levels and talks about the future of continuous health awareness. The podcast also explores the significance of continuous glucose monitoring, the limitations of glucose detecting sensors, and the potential applications of wearable device data in healthcare.
undefined
Feb 6, 2024 • 27min

Transitioning From Gymnast to Investor with Aly Raisman

Former gymnast Aly Raisman discusses her transition to being an investor, her passion for financial literacy, and her appreciation for founders' work ethic. They also talk about mental health during their gymnastics career, the importance of therapy and nutrition, and the challenges in the healthcare system.
undefined
17 snips
Jan 30, 2024 • 33min

Finding PMF in Healthcare (After Tasting it Elsewhere) with Eren Bali and Max Cohen

Eren Bali, founder and CEO of Carbon Health, and Max Cohen, cofounder and CEO of Sprinter Health, discuss their experiences transitioning from tech to healthcare, finding product-market fit, tracking KPIs, and adapting to changes in the investor landscape. They reflect on the complexity of the healthcare industry, the challenges of addressing individual needs, and the advantages and opportunities for tech companies in healthcare
undefined
4 snips
Jan 23, 2024 • 31min

IRA, AI Regulation, and the Future with Joe Grogan

Joe Grogan, senior fellow at the Leonard D. Schaeffer Center for Health Policy and Economics, discusses his experience during the early days of the COVID pandemic. He shares insights on the Inflation Reduction Act's impact on pharmaceutical R&D and the future of AI regulation.
undefined
Jan 16, 2024 • 30min

Drag & Drop Genome Editing

Rahul Kakkar, John Finn, and Jorge Conde discuss PASTE, a genome editing technique that could make cell therapy more accessible. They explore advancements in genomic medicine, CRISPR technology, and focus on genetic diseases of the liver and autoimmune diseases. They also touch on challenges in transitioning from research to patients and share anecdotes about facial hair.
undefined
Jan 9, 2024 • 39min

Past, Present, and Future of AI with Vijay Pande

Vijay Pande, founding partner of Bio + Health, discusses the evolution of AI, the pioneers in the field, and the shift to biology. He highlights the advancements in biology, the challenges of obtaining data, and the importance of multiple perspectives in understanding cells. The podcast also explores the opportunities in AI startups and how AI is being integrated into life sciences and healthcare companies.
undefined
10 snips
Jan 4, 2024 • 32min

Fireside Chat with Sean Duffy

Sean Duffy, cofounder and CEO of Omada Health, joins Vijay Pande to discuss the building and growth of Omada, the future of AI in healthcare, and the challenges of using technology in a caregiving environment. They also reflect on their personal and professional development over the years and highlight innovative solutions to scaling healthcare.
undefined
Jan 1, 2024 • 56sec

Introducing: Raising Health

The podcast 'Raising Health' explores technological advancements in healthcare, including analyzing health data, personalized recommendations, gene therapy, and the role of artificial intelligence in healthcare.
undefined
Dec 12, 2023 • 31min

Generalist Medical AI with Pranav Rajpurkar

Pranav Rajpurkar, PhD discusses the future of generalist medical AI, its potential as a support system for physicians, and the challenges of developing a model encompassing all medical knowledge. They explore the transition to deep learning, feasibility of building a generalist AI, and the timeline for its arrival.
undefined
Dec 5, 2023 • 27min

Gate Unveiling with Jordi Mata-Fink

Jordi Mata-Fink, co-founder of Gate Bioscience, discusses their work on commercializing a novel class of therapeutics called 'molecular gates' targeting extracellular proteins. He explores the power of platform-based problem-solving and team building in biotech startups, as well as the potential of small molecules to overcome therapeutic challenges. The episode also delves into the secretory translocon and the opportunities it presents for therapeutic intervention.

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app